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one of the most commonly applied enzyme histochemical 
methods today. Chloroacetate esterase and tartrate-resis-
tant phosphatase are both resistant to formalin fixation, 
EDTA decalcification and paraffin embedding. Early enzyme 
histochemical insight into development of a pathologic tis-
sue lesion and evaluation of function and vitality of tissue 
enhance our understanding of the pathophysiology of dis-
eases. In this process, enzyme histochemistry constitutes a 
valuable complement to conventional histology, immuno-
histochemistry and molecular pathology for both diagnostic 
and experimental pathology.  Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 Enzyme histochemistry is a morphological tech-
nique applied to functional questions in histopathology 
( fig. 1 ). Enzyme histochemistry constitutes a link be-
tween biochemistry and morphology  [1, 2] and provides 
important information complementary to conventional 
histology, immunohistochemistry and molecular pa-
thology.
 The father of enzyme histochemistry was A.G.P. Pearse 
 [3, 4] . Since the initial introduction of enzyme histo-
chemistry, reactions involving almost all enzymes known 
have been applied to sections of any human tissue. It was 
applied in the diagnosis of peracute myocardial infarc-
tion  [5, 6] , the diagnosis of celiac disease  [7–15] , of brain 
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 Abstract 
 Enzyme histochemistry serves as a link between biochemis-
try and morphology. It is based on metabolization of a sub-
strate provided to a tissue enzyme in its orthotopic localiza-
tion. Visualization is accomplished with an insoluble dye 
product. It is a sensitive dynamic technique that mirrors even 
early metabolic imbalance of a pathological tissue lesion, 
combined with the advantage of histotopographic enzyme 
localization. With the advent of immunohistochemistry and 
DNA-oriented molecular pathology techniques, the poten-
tial of enzyme histochemistry currently tends to be under-
recognized. This review aims to draw attention to the broad 
range of applications of this simple, rapid and inexpensive 
method. Alkaline phosphatase represents tissue barrier 
functions in brain capillaries, duodenal enterocyte and prox-
imal kidney tubule brush borders. Decrease in enzyme his-
tochemical alkaline phosphatase activity indicates serious 
functional impairment. Enzyme histochemical increase in ly-
sosomal acid phosphatase activity is an early marker of isch-
emic tissue lesions. Over the last four decades, acetylcholin-
esterase enzyme histochemistry has proven to be the gold 
standard for the diagnosis of Hirschsprung disease and is 
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lesions  [16–19] , and in tumor treatment  [20–30] , to name 
only a few examples.
 Traditionally, chloroacetate esterase and tartrate-re-
sistant acid phosphatase have been developed for assess-
ment of myelopoiesis and osteoclastogenesis, respectively 
 [31–37] .
 Currently, besides lactic dehydrogenase and succinic 
dehydrogenase in the neuropathological investigation of 
muscle biopsies, acetyl cholinesterase remains the most 
commonly performed enzyme histochemical reaction in 
a standard pathology laboratory  [38, 39] .
 After widespread application of enzyme histochem-
istry up to the 1970s, immunohistochemistry rapidly 
gained territory. Immunohistochemistry then arose as a 
new technique, and is now widely applicable to standard 
paraffin-embedded specimens in pathology, opening 
vast possibilities for tumor diagnosis and research. Fur-
thermore, with the advent of molecular pathology, the 
potential of enzyme histochemistry is currently underes-
timated.
 The aim of this review is to show in a number of es-
sential examples, which causative mechanisms can be 
elucidated by enzyme histochemistry. This method is not 
limited to the diagnosis of Hirschsprung disease  [40] but 
permits early insights into a range of different pathologi-
cal processes  [39] .
 General Principles of Enzyme Histochemical 
Techniques 
 Enzyme histochemistry combines the biochemical 
analysis of enzyme activity with information on its topo-
graphical localization. The basic techniques of enzyme 
histochemistry are described in detail in the laboratory 
manuals of Pearse  [4] , Meier-Ruge et al. [38] , Meier-Ruge 
and Bruder  [40] and Lojda and Schiebler  [41] . In order to 
briefly acquaint the reader unfamiliar with these tech-
niques, we describe two of the most important enzyme 
histochemical techniques in detail.
 In a dehydrogenase reaction, enzyme substrates like 
sodium succinate or sodium  L -lactate are oxidized and
a stoichiometric color indicator tetranitrotetrazolium 
chloride blue (TNBT) is reduced to black or blue forma-
zan. The formazan immediately binds to local protein 
and permits the precise localization of the enzyme dehy-
drogenase in a particular tissue compartment. The en-
zyme histochemical reaction follows the stoichiometric 
principles of biochemistry. Whereas biochemistry is ap-
plied to tissue homogenates or extracts, expressing en-
zyme activity in turnover rates, enzyme histochemistry 
indicates the locus of an enzyme in the tissue section.
 A second group of enzyme reactions use diazonium 
salt instead of tetrazolium chloride as color indicator. En-
zymes stained with this kind of reaction are mainly es-
terases and phosphatases. The ester group or phosphate 
group of a naphthyl salt is split off by the enzyme reaction 
and the naphthyl rest couples to a diazo-salt and stains 
the esterase- or phosphatase-containing compartment 
like in a formazan color reaction  [38, 41–43] .
 Almost all enzyme histochemical investigations are 
performed with frozen tissue, because most enzymes are 
inactivated by formalin fixation. In fact, formalin fixa-
tion is even employed to stop enzyme histochemical reac-
tions like lactic dehydrogenase or succinic dehydroge-
nase reactions  [40] . With the requirement of frozen tis-
sue, transportation and storage of biopsies or surgical 
specimens become an issue and lead to frequently asked 
questions in daily routine practice. It is recommended to 
freeze specimens on dry ice (CO 2 ) at –80 ° C or in isopen-
tane stored in a –25 ° C freezer. Liquid nitrogen carries the 
disadvantage of cracking freezing artifact in large tissue 
specimens  [43] . After freezing as described, the tissue can 
be stored without loss of enzymatic activity for longer pe-
riods at –25 ° C in a small Eppendorf tube (biopsies) or 
plastic bag (surgical resections).
 Similarly, an important technical point to stress is the 
minimal section thickness. It is recommendable to cut 
Biotransformational
pathology
Molecular
pathology
Cellular
pathology
Immuno-
histochemistry
Static
pathology
(pathol. anatomy)
Enzyme
histochemistry
Pathobiology
(pathophysiology)
 Fig. 1.  Schematic representation of conventional stains (left) set 
against enzyme histochemistry (right). Both techniques function 
as complements, but show different tissue characteristics: (1) con-
ventional HE stain delineates the different tissue compartments; 
(2) enzyme histochemistry highlights functional alterations. It is 
a tool to elucidate the pathophysiology of a particular disease, as 
for example disturbance of blood-brain barrier with decrease in 
capillary alkaline phosphatase in the brain, therapy resistance to 
anticancer treatment with increase in glycolytic turnover in breast 
cancer. 
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cryostat sections at 15   m in order to overcome the min-
imal enzyme activity threshold for the enzymatic start-
ing reaction  [43] . It is important to be aware that a 15-
  m-thick cryostat section loses 70% of its thickness by 
thawing, spreading and drying, resulting in a final thick-
ness of 4   m, whereas an originally 4-  m-thick native 
cryostat section has a final thickness of 1.2   m, so that in 
thin sections the enzyme reaction does not reliably de-
velop because the enzyme activity may drop below the 
enzymatic starting reaction  [43] .
 Enzyme Histochemistry versus Biochemical Analysis 
 Biochemistry employs tissue extracts or tissue homog-
enates. Analysis of such tissue specimens reveals a gen-
eral increase or decrease in enzyme activity measured in 
turnover rates. In contrast, enzyme histochemistry local-
izes enzyme activity to cells or tissue compartments but 
does not provide the exact quantitative data of biochem-
ical analysis. The capability to localize enzyme histo-
chemical activity on a cellular level justifies the Greek 
prefix ‘-topo’ in the term ‘enzyme histotopochemistry’, 
distinguishing enzyme histochemistry from biochemis-
try.
 Overall, there is a good correlation between histo-
chemically judged enzyme activity per volume (area  ! 
thickness) and biochemically determined activity per 
milligram tissue  [1] .
 The strength of biochemistry lies in the potential for 
quantification: biochemistry permits exact quantifica-
tion of enzymatic turnover rates, whereas enzyme histo-
chemistry has the disadvantage of a lack of reliable quan-
tification, so that only semiquantitative assessment is 
achieved if microspectrophotometry is applied. However, 
the elective staining of a particular tissue structure in en-
zyme histochemistry permits precise morphometric size 
measurement by means of optic electronic morphometry 
equipment, e.g. the ASBA3 system  [44]  (compare  fig. 15 
and  16 ). The level of monochromic light absorption per-
mits semiautomatic calculation, e.g. of the extension of 
an ischemic brain infarct. Another example of morpho-
metric analysis in conjunction with enzyme histochem-
istry is the determination of nerve cell size, nerve cell 
number and nerve cell distance of the myenteric plexus 
stained with lactic dehydrogenase enzyme histochemis-
try  [40] (compare  fig. 5 ).
 Biochemistry incurs the disadvantage of tissue dilu-
tion effect by tissue surrounding the structure of interest. 
Chromatography, electrophoresis or density gradient 
centrifugation is applied to compensate for this disad-
vantage. Compared to enzyme histotopochemistry, the 
biochemical procedure is therefore time-consuming but 
nevertheless falls short to localize the altered structure, 
which is more easily demonstrated by enzyme histotopo-
chemical means.
 Applications of Enzyme Histochemistry as a Tool in 
Diagnostic Pathology and Pathobiology 
 Enzyme histochemistry can be used in pathohistolog-
ical routine diagnosis as it has simple technical require-
ments. Enzyme histotopochemical demonstration of ace-
tylcholinesterase activity in frozen colon mucosal biop-
sies has proven a reliable tool and is the current gold 
standard in the diagnosis of Hirschsprung disease today 
 [2, 40, 45–48] ( fig. 2 ). In particular, in the diagnosis of 
ultrashort Hirschsprung disease and aganglionosis lim-
ited to the internal sphincter, the so-called sphincter 
achalasia, the acetylcholinesterase reaction is the choice 
technique  [49–52] .
 Another attractive application of enzyme histochem-
istry is the verification of a peracute myocardial infarc-
tion during autopsy. This can be performed macroscopi-
AChE
 Fig. 2. Hirschsprung disease with characteristic increase in ace-
tylcholinesterase activity in parasympathetic nerve fibers of mus-
cularis mucosae and lamina propria mucosae (left), compared to 
normally innervated rectum mucosa (right).  ! 90. The increased 
unmodulated release of acetylcholine from the sacral roots S2–S5, 
due to aplasia of nerve cells of the enteric nervous system in the 
rectum, leads to elevation of acetylcholinesterase activity as a re-
liable diagnostic parameter. 
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cally by a succinic dehydrogenase reaction in a Petri dish 
with succinate (13 g in 100 ml phosphate buffer at pH 7.4) 
and neotetrazolium chloride (100 mg dissolved in phos-
phate buffer). The reduced succinic dehydrogenase ac-
tivity in the ischemic area of the myocardial infarction 
can quickly and reliably be recognized macroscopically 
 [5, 6] .
 The enzyme alkaline phosphatase conveys a range of 
important information. On the one hand, alkaline phos-
phatase is eliminated by bile secretion. An increase or ac-
cumulation of alkaline phosphatase in bile capillaries of 
the liver indicates a disturbed mechanism of secretion 
 [53–57] ( fig. 3 ). Toxic lesions of the liver, infectious hepa-
titis  [58–60] or seriously congested liver  [57, 61] show 
similar pictures. These observations demonstrate that a 
simple enzyme histochemical reaction for alkaline phos-
phatase indicates a functional disturbance of the liver in 
biopsy or autoptic liver tissue. In addition to the transport 
function of bile capillaries for alkaline phosphatase, this 
enzyme represents a barrier function and is observed in 
structures with directed transport function. Alkaline 
phosphatase of brain capillaries represents the blood-
brain barrier  [39, 62, 63] .
 The alkaline phosphatase of the brush border of the 
proximal renal tubules is responsible for absorption of 
metabolites from the primary urine and is quite sensitive 
to toxic or ischemic injury  [64–66] ( fig. 4 ).
 Of particular diagnostic value is alkaline phosphatase 
in the brush border of the duodenal mucosa in the diag-
nosis of celiac disease. Alkaline phosphatase activity is 
high in young adults and low in postweaning children  [7] . 
This enzyme is a fairly sensitive parameter in the diagno-
sis and therapy of celiac disease. Similarly, malabsorption 
Alkaline phosphatase
 Fig. 3. Liver in burn shock with impaired elimination of alkaline 
phosphatase (right). Normal liver (left) as depicted in an alkaline 
phosphatase reaction. Hemalum counterstain.  ! 60. 
Alkaline
phosphatase SDH
 Fig. 4. Toxic kidney injury in rat due to 5,7-dichloro-8-hydroxy-
chinaldine. Left: focal decrease in alkaline phosphatase reaction 
of the brush border in the proximal renal tubule.  ! 60. Right: fo-
cal decrease in succinic dehydrogenase activity in distal renal tu-
bule epithelium (disturbed reabsorption of primary urine). 
 ! 250. 
LDH
 Fig. 5. Hypoganglionosis of myenteric plexus (right). Normal my-
enteric plexus (left). Lactic dehydrogenase reaction.  ! 160. Hypo-
ganglionosis is a common cause of chronic constipation. 
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syndromes show loss of alkaline phosphatase in the brush 
border of enterocytes  [8–12] . The reappearance of an al-
kaline phosphatase brush border of enterocytes in duo-
denal mucosal biopsies is a clear indicator of compen-
sated celiac disease. It is a parameter superior to the his-
tological findings of villous atrophy. With the progression 
of celiac disease, the dehydrogenase activity of entero-
cytes decreases  [46] . The tremendous number of publica-
tions illustrates the diagnostic and therapeutic difficul-
ties of celiac disease  [13–15] .
 Examination of seromuscular biopsies or resected 
specimens with lactic, succinic dehydrogenase and ni-
troxide synthetase reactions permitted the morphomet-
ric characterization of hypoganglionosis as a cause of 
chronic constipation  [67, 68] . Proximal to the agangli-
onic segment, often, a hypoganglionic segment is ob-
served with scanty nerve cells and ganglia with increased 
interganglionic distances  [40, 69] ( fig. 5 ). The hypogan-
glionic segment shows a decreased acetylcholinesterase 
activity in the muscularis propria, indicating disturbed 
motility ( fig. 6 ). Over recent years, enzyme histotopo-
chemistry has contributed to remarkably improved un-
derstanding of the pathophysiology of chronic constipa-
tion  [40] .
 Dehydrogenase reactions are of interest to examine 
the vitality of a particular tissue. In kidney biopsies, not 
only alkaline phosphatase is of interest but also the dehy-
drogenase activity of the tubulus epithelium  [64–66] 
 ( fig. 4 ). The latter demonstrates the vitality of the kidney, 
which may be of interest in transplanted kidneys.
 In oncology, dehydrogenase activity of a tumor dem-
onstrates its vitality with the impact on the efficiency of 
cytostatic therapy or radiotherapy. Is has been clearly 
shown that tumor tissue with high glycolytic activity is 
particularly resistant to radiotherapy  [20, 70, 71] . High 
glycolytic tumor activity is revealed in enzyme histo-
chemistry for succinic and lactic dehydrogenase ( fig. 7 ). 
Enzyme histochemistry for dehydrogenase provides a 
quick, efficient and inexpensive orientation on the actual 
energy metabolism of a particular tumor and on the ex-
pected efficacy of the therapeutic strategy  [21, 22] . This 
opens a fascinating field of research in monitoring cancer 
treatment. Glycolytic inhibitors, depriving cancer cells of 
their energy supply, are under discussion for a new class 
of anticancer drugs  [23–25] , and it has recently been dem-
onstrated that cancer cells with high glycolytic rate  [26–
28] are characterized by high drug resistance  [27–30] .
 Craniocerebral trauma and temporary ischemia is of-
ten hard to prove in a hemalum-eosin stain. Enzyme his-
tochemistry shows a significant decrease in lactic and 
succinic dehydrogenase activity in Purkinje cells of the 
cerebellum under these conditions ( fig. 8 ). Lesions of 
blood-brain barrier are characterized by focal or diffuse 
decrease in alkaline phosphatase in brain capillaries  [72, 
73] ( fig. 9 ). This kind of brain lesions can be observed in 
AChE
 Fig. 6. Right: Hypoganglionosis of myenteric plexus shown in an 
acetylcholinesterase reaction with low enzyme activity in circular 
muscle layer of the muscularis propria. Low acetylcholinesterase 
activity is an indicator of disturbed colon motility. Left: Normal 
myenteric plexus and acetylcholinesterase activity in circular 
muscle layer in a patient with normal motility.  ! 180. 
LDH
 Fig. 7. Breast cancer with focal decrease in lactic dehydrogenase 
activity as a result of radiotherapy.  ! 60. Enzyme histochemistry 
of glycolytic enzymes of tumor biopsies permits an evaluation of 
anticancer therapy. 
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boxers  [16] . Only few papers in the literature deal with 
these particular lesions  [17–19] . The brain is particularly 
suited for a postmortem enzyme histochemical examina-
tion, because autolytic processes start fairly late in the 
adult brain.
 Senile plaques in the brain can be electively highlight-
ed by their intense acid phosphatase activity ( fig. 10 ). 
Acid phosphatase is a key enzyme of lysosomal activity. 
The combination of an acid phosphatase reaction with a 
Timm staining reveals a decrease of synapses in the sur-
roundings of senile plaques in the hippocampus ( fig. 11 ). 
Lysosomal enzymes may be responsible for the formation 
of senile plaques  [74] .
Normal Contusio
 Fig. 8. Cerebellum with contusio. Decrease of lactic dehydroge-
nase activity in Purkinje cells (right) in comparison to normal 
cerebellum (left).  ! 180. 
Normal Alkal. Pase Contusio
 Fig. 9. Brain edema after contusio cerebri. Disturbed blood-brain 
barrier with decreased capillary alkaline phosphatase activity 
(right) and normal capillary net (left).  ! 50. 
Acid phosphatase Acid phosphatase
 Fig. 10. Senile plaques stained with acid phosphatase in the den-
tate gyrus of hippocampus (left;  ! 120) and higher magnification 
(right; acid phosphatase without counterstain;  ! 400). 
Acid
phosphatase
Timm reaction
 Fig. 11. Decrease in synaptic density as visualized with a Timm 
reaction in vicinity of senile plaques (dentate gyrus of hippocam-
pus).  ! 120. Timm reaction and acid phosphatase reactions are 
performed in consecutive serial sections. The Timm reaction was 
developed to visualize structures like axons and is currently ap-
plied in experimental pathology research  [82] . The Timm reac-
tion shows that senile plaques are associated with a dropout of 
specific neuronal structures in the area of plaque formation. 
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 Applications of Enzyme Histochemistry in 
Experimental Pathology 
 Enzyme histochemical investigations on causes of in-
toxication, drug side effects or a particular disease are 
usually performed in laboratory animals. Enzyme histo-
chemistry permits monitoring of a dose-dependent in-
toxication and time-related changes in different organs of 
rats, mice, dogs, cats and other laboratory animals.
 Cats as twilight animals with nocturnal activity have 
a retina rich in rods. Such retinas have a particularly high 
metabolism of the visual cells and a high sensitivity to 
toxic side effects. The thioridazine analogue piperidyl-
chlorophenothiazine caused night blindness and pig-
mentation of the retina in clinical trials with high dosage 
of the tranquilizer. In laboratory cats, it was possible to 
demonstrate that piperidylchlorophenothiazine inhibits 
glycolytic enzyme activity of rods ( fig. 12 ), accompanied 
by an increased desquamation of peripheral rod seg-
ments. Phagocytosis and storage of these light absorbing 
structures from the rods in the pigment epithelium causes 
pigmentation of the cat retina  [75] . Elucidation of this 
drug side effect was rendered possible by enzyme histo-
chemical analysis.
 The chloroquinone retinopathy is characterized by a 
toxic edema of the pigment epithelium  [76, 77] ( fig. 13 ). 
This implies a defect of the visual field of the retina  [77] , 
because pigment epithelium is not further able to isomer-
ize all-trans retinine to 11-cis retinine which is necessary 
for rhodopsin synthesis. The reason of this localized side 
effect of chloroquine in the retina is its accumulation on 
choroid melanin and high chloroquine levels in the vitre-
ous fluid damaging the pigment epithelium.
 The development of an ischemic brain infarct by ex-
perimental occlusion of the middle cerebral artery in pri-
mates was studied with the lysosomal enzyme acid phos-
phatase. In this trial, the time-dependent increase in the 
ischemic brain infarct was studied  [78] ( fig. 14 ). A circu-
latory arrest in neonatal pigs demonstrated the earliest 
morphological changes after 90 min  [78] . In primates, the 
release of acid phosphatase starts immediately after clip-
ping the medial cerebral artery. The extension of the isch-
emic brain infarct becomes obvious 20–30 min later. 
Acid phosphatase permits a morphometric, time-depen-
dent follow-up of the extension of the infarct size  [78–80] 
( fig. 15 ). Morphometric measurements of alkaline phos-
phatase-positive capillaries in combination with the size 
of the ischemic infarct show that the therapeutic window 
for an effective infarct treatment is limited to the first 4 h 
with declining time-dependent effectiveness  [78, 81] .
K LDH K SDH
 Fig. 12. Cat retina with inhibition of dehydrogenase activity in the 
ellipsoids of rods by experimental phenothiazine retinopathy 
(left) in comparison with normal retina (right). Lactic and suc-
cinic dehydrogenase.  ! 120. The decrease in dehydrogenase ac-
tivity in rod ellipsoids is accompanied by an increased desquama-
tion of peripheral rod segments with the consequence of night 
blindness. 
 Fig. 13. Right: Chloroquine retinopathy with toxic edema of pig-
ment epithelium (brown/red color), which blocks the isomeriza-
tion of all-trans retinine to II-cis retinine, thereby decreasing the 
visual field of the affected eye. Left: normal retina, acid phospha-
tase (brown/red color) with light green counterstain.  ! 240. 
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 Acid phosphatase offers the possibility to objectify the 
extension of the penumbra by morphometric techniques, 
which is actually much smaller than expected by X-ray 
investigation ( fig. 16 ).
 Performance of Enzyme Histochemistry on 
Formalin-Fixed and Paraffin-Embedded Tissue 
 Enzyme histochemistry is also frequently applied in 
hematology. Chloroacetate esterase is commonly used as 
a marker of myelopoiesis. A major advantage of this es-
terase is its stability to formalin fixation and paraffin em-
bedding. Low levels of chloroacetate esterase in bone 
marrow smears of patients with promyelocytic leukemia 
are considered to indicate a bad prognosis  [31] . As a non-
specific marker  [32] , in hematological laboratories it is 
routinely applied in conjunction with a series of different 
enzymes as   -glucuronidase,   -glucosaminidase, acid 
phosphatase, peroxidase and a number of dehydroge-
nases of the citric cycle  [33] .
 Tartrate-resistant acid phosphatase is an enzyme lo-
calized to mature osteoclasts  [34, 35] . Tartrate-resistant 
acid phosphatase is similarly resistant to formalin fixa-
tion, paraffin embedding and even EDTA decalcifica-
tion, and is applied to visualization of osteoclasts in bone 
biopsies and osteopetrosis after bone marrow transplan-
tation  [35] . Serum levels of tartrate-resistant acid phos-
phatase are determined for monitoring bone metastases 
2 h 24 h
 Fig. 14. Ischemic brain infarct in a primate brain (acid phospha-
tase reaction). In the first 2 h (left), only a release of lysosomal acid 
phosphatase is observed without manifest necrosis. After 24 h 
(right;  ! 60), extensive necrosis is established, and acid phospha-
tase is only observed at the border between necrosis and sur-
rounding brain tissue. This distinct staining of the ischemic area 
permits optimal semiautomated morphometric measurement, as 
represented in figures 15 and 16. 
0
0.5
2
4
6
Vo
lu
m
e 
(m
m
3 )
4 12
Time after occluding medial cerebral artery (h)
24 48
Ncl
caudatus
Ncl lentiformis
Arteriae lenticulo-striatae
Cortex insulae
Medial
cerebral artery
ALS
 Fig. 15. Morphometric measurement of the time-dependent in-
crease in infarct size. Infarct size is clearly marked by the released 
acid phosphatase bordering the ischemic area. 
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 Fig. 16. Morphometry of extension of penumbra of an ischemic 
brain infarct (nucleus lentiformis). Acid phosphatase.  ! 90. Acid 
phosphatase stains the edematous border of the brain infarct. As 
a consequence of the flow of the cerebrospinal fluid, the edema-
tous border with increased acid phosphatase activity extends 
more in the direction towards the lateral ventricle than the direc-
tion of the cortex. 
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 [36] and in patients with prosthetic hip replacement to 
predict periprosthetic osteopenia  [37] .
 However, it should be stated that none of these two re-
actions applicable to formalin-fixed, paraffin-embedded 
tissue equals the dynamics and stoichiometry of classical 
enzyme histochemical reactions like lactic dehydro-
genase, succinic dehydrogenase, alkaline phosphatase, 
acid phosphatase, ATPase, glucuronidase and other en-
zymes.
 Conclusion 
 Enzyme histotopochemistry is a functional technique 
providing insights into the pathophysiology and pathobi-
ology of a particular pathological process. It has the po-
tential to demonstrate the vitality of cells or a particular 
tissue. Enzyme histochemistry serves to detect early met-
abolic changes in biopsy and autopsy tissue before mani-
festation on HE staining or immunohistochemistry. As 
such, it constitutes a valuable complement to other spe-
cial techniques, i.e. immunohistochemistry and molecu-
lar pathology.
 An exclusive diagnostic domain of enzyme histo-
chemical analysis is the aganglionosis of the distal rec-
tum mucosa, which cannot reliably be diagnosed by con-
ventional histology alone. Apart from current diagnostic 
applications in muscle biopsy analysis and the diagnosis 
of Hirschsprung disease, enzyme histochemistry pro-
vides access to a wide range of investigations in experi-
mental pathology and toxicology as a pathophysiological 
supplement to conventional histology. 
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